Influenza vaccines

Ended Awarded Last action

Contract number
HHSD2002018F96382
Awardee
Awarding agency
Obligated
$1,319,230

Award facts

Opportunity
  • 2018Q67715 Solicitation number
Contract value 100% obligated
$1,319,230.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Durham, NC 27709, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 1 -$142,360
Original award $1,461,590

About this award

This is a federal contract award by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to GlaxoSmithKline, LLC, a pharmaceutical company, for the delivery of influenza vaccines. The contract is a Delivery Order issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with a Firm Fixed Price pricing type and a potential value of $1,319,230.00. There was no set-aside designation used for this award. GlaxoSmithKline has provided a range of pharmaceutical goods and services as the prime contractor on federal contracts, including influenza virus and hepatitis vaccines, COVID-19 treatments, vaccine adjuvants, and antiviral medications. The company also holds several federal contract indefinite delivery vehicles for pharmaceutical products and vaccines with agencies such as the Department of Veterans Affairs and the Defense Logistics Agency.

Quick answers

Who was awarded contract HHSD2002018F96382?

HHSD2002018F96382 was awarded to Glaxosmithkline, LLC by CDC Pittsburgh (Centers for Disease Control and Prevention) on November 17, 2017.

How much is contract HHSD2002018F96382 worth?

The government has obligated $1,319,230 on HHSD2002018F96382.

Is contract HHSD2002018F96382 an order under another contract?

Yes. HHSD2002018F96382 is a delivery order under V797P2298D, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract HHSD2002018F96382 competed?

The extent of competition for HHSD2002018F96382 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award